Literature DB >> 16648371

LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome.

E Volikos, J Robinson, K Aittomäki, J-P Mecklin, H Järvinen, A M Westerman, F W M de Rooji, T Vogel, G Moeslein, V Launonen, I P M Tomlinson, A R J Silver, L A Aaltonen.   

Abstract

BACKGROUND: LKB1/STK11 germline mutations cause Peutz-Jeghers syndrome (PJS). The existence of a second PJS locus is controversial, the evidence in its favour being families unlinked to LKB1 and the low frequency of LKB1 mutations found using conventional methods in several studies. Exonic and whole gene deletion or duplication events cannot be detected by routine mutation screening methods.
OBJECTIVE: To seek evidence for LKB1 germline deletions or duplications by screening patients meeting clinical criteria for PJS but without detected mutations on conventional screening.
METHODS: From an original cohort of 76 patients, 48 were found to have a germline mutation by direct sequencing; the remaining 28 were examined using multiplex ligation dependent probe amplification (MLPA) analysis to detect LKB1 copy number changes.
RESULTS: Deletions were found in 11 of the 28 patients (39%)--that is, 14% of all PJS patients (11/76). Five patients had whole gene deletions, two had the promoter and exon 1 deleted, and in one patient exon 8 was deleted. Other deletions events involved: loss of exons 2-10; deletion of the promoter and exons 1-3; and loss of part of the promoter. No duplications were detected. Nine samples with deletions were sequenced at reported single nucleotide polymorphisms to exclude heterozygosity; homozygosity was found in all cases. No MLPA copy number changes were detected in 22 healthy individuals.
CONCLUSIONS: These results lessen the possibility of a second PJS locus, as the detection rate of germline mutations in PJS patients was about 80% (59/76). It is suggested that MLPA, or a suitable alternative, should be used for routine genetic testing of PJS patients in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648371      PMCID: PMC2564523          DOI: 10.1136/jmg.2005.039875

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  31 in total

Review 1.  Peutz-Jeghers syndrome.

Authors:  I P Tomlinson; R S Houlston
Journal:  J Med Genet       Date:  1997-12       Impact factor: 6.318

2.  Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2.

Authors:  K Buchet-Poyau; H Mehenni; U Radhakrishna; S E Antonarakis
Journal:  Cytogenet Genome Res       Date:  2002       Impact factor: 1.636

3.  A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.

Authors:  A Hemminki; D Markie; I Tomlinson; E Avizienyte; S Roth; A Loukola; G Bignell; W Warren; M Aminoff; P Höglund; H Järvinen; P Kristo; K Pelin; M Ridanpää; R Salovaara; T Toro; W Bodmer; S Olschwang; A S Olsen; M R Stratton; A de la Chapelle; L A Aaltonen
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

4.  Complete germline deletion of the STK11 gene in a family with Peutz-Jeghers syndrome.

Authors:  Nathalie Le Meur; Cosette Martin; Pascale Saugier-Veber; Géraldine Joly; Françoise Lemoine; Hélène Moirot; Annick Rossi; Bruno Bachy; Annick Cabot; Pascal Joly; Thierry Frébourg
Journal:  Eur J Hum Genet       Date:  2004-05       Impact factor: 4.246

Review 5.  Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.

Authors:  James Brugarolas; William G Kaelin
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

6.  STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer.

Authors:  N Resta; C Simone; C Mareni; M Montera; M Gentile; F Susca; R Gristina; S Pozzi; L Bertario; P Bufo; N Carlomagno; M Ingrosso; F P Rossini; R Tenconi; G Guanti
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

7.  Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.

Authors:  C F Taylor; R S Charlton; J Burn; E Sheridan; G R Taylor
Journal:  Hum Mutat       Date:  2003-12       Impact factor: 4.878

8.  Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.

Authors:  Yaping Wang; Waltraut Friedl; Christof Lamberti; Matthias Jungck; Micaela Mathiak; Constanze Pagenstecher; Peter Propping; Elisabeth Mangold
Journal:  Int J Cancer       Date:  2003-02-20       Impact factor: 7.396

9.  Nine novel germline mutations of STK11 in ten families with Peutz-Jeghers syndrome.

Authors:  H Nakagawa; K Koyama; Y Miyoshi; H Ando; S Baba; M Watatani; M Yasutomi; N Matsuura; M Monden; Y Nakamura
Journal:  Hum Genet       Date:  1998-08       Impact factor: 4.132

10.  Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene.

Authors:  F M Richards; P A Crossey; M E Phipps; K Foster; F Latif; G Evans; J Sampson; M I Lerman; B Zbar; N A Affara
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

View more
  49 in total

1.  Functional consequence of the STK11 exon 7 duplication mutation identified in a Korean child with Peutz-Jeghers syndrome.

Authors:  Jian-Min Chen
Journal:  Dig Dis Sci       Date:  2011-01       Impact factor: 3.199

Review 2.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

Review 3.  Hamartomatous polyposis syndromes.

Authors:  Daniel Calva; James R Howe
Journal:  Surg Clin North Am       Date:  2008-08       Impact factor: 2.741

Review 4.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

5.  [LKB1 regulates epithelial-mesenchymal transition in Peutz-Jeghers hamartoma and intestinal epithelial cells].

Authors:  Chao Zhong; Liang Peng; Ran Li; Jing Chen; Xin-Qi Chen; Di Zeng; Xiao-Ping Xu; Zhi-Qing Wang; Chu-di Chen; Ya-Dong Wang; Ai-Min Li; Si-de Liu; Bao-Ping Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

6.  First report of somatic mosaicism for mutations in STK11 in four patients with Peutz-Jeghers syndrome.

Authors:  Victoria McKay; Diane Cairns; David Gokhale; Roger Mountford; Lynn Greenhalgh
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

7.  Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.

Authors:  Chongjuan Wei; Christopher I Amos; Nianxiang Zhang; Jing Zhu; Xiaopei Wang; Marsha L Frazier
Journal:  Cancer Lett       Date:  2009-01-14       Impact factor: 8.679

Review 8.  An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review.

Authors:  Julian Daniell; John-Paul Plazzer; Anuradha Perera; Finlay Macrae
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

9.  The genomics of colorectal cancer: state of the art.

Authors:  Andrew D Beggs; Shirley V Hodgson
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

10.  Mutations in STK11 gene in Czech Peutz-Jeghers patients.

Authors:  Peter Vasovcák; Alena Puchmajerová; Jan Roubalík; Anna Krepelová
Journal:  BMC Med Genet       Date:  2009-07-19       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.